These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15554329)

  • 21. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a 5-minute rapid test for detecting Vibrio cholerae O139.
    Thattiyaphong A; Okada K; Khangrang S; Nispa W; Sawanpanyalert P; Honda T
    Southeast Asian J Trop Med Public Health; 2013 May; 44(3):448-55. PubMed ID: 24050076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-emergence of Vibrio cholerae O139 in Pakistan: report from a tertiary care hospital.
    Jabeen K; Hasan R
    J Pak Med Assoc; 2003 Aug; 53(8):335-8. PubMed ID: 14558737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh.
    Chowdhury F; Khan AI; Harris JB; LaRocque RC; Chowdhury MI; Ryan ET; Faruque AS; Calderwood SB; Qadri F
    Pediatr Infect Dis J; 2008 Nov; 27(11):986-92. PubMed ID: 18833030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139.
    Asaduzzaman M; Ryan ET; John M; Hang L; Khan AI; Faruque AS; Taylor RK; Calderwood SB; Qadri F
    Infect Immun; 2004 Aug; 72(8):4448-54. PubMed ID: 15271902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lytic effect of Vibrio cholerae elastase on gram-positive and -negative bacteria.
    Kaur M; Gupta M; Tripathi KK; Gupta KG
    Folia Microbiol (Praha); 1990; 35(3):183-9. PubMed ID: 2210489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and immunogenicity of conjugate based on hydrazine-treated lipopolysaccharide antigen of Vibrio cholerae O139.
    Fleischhackerová A; Farkaš P; Cížová A; Bystrický S
    Biosci Biotechnol Biochem; 2014; 78(11):1817-24. PubMed ID: 25070088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and characterization of an auxotrophic ctxA mutant of O139 Vibrio cholerae.
    Chan M; Cheong TG; Kurunathan S; Chandrika M; Ledon T; Fando R; Lalitha P; Zainuddin ZF; Ravichandran M
    Microb Pathog; 2010 Nov; 49(5):211-6. PubMed ID: 20558271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of antibody and complement function in host defense against bacterial infection.
    Joiner KA; Fries LF; Frank MM
    Immunol Lett; 1987 Feb; 14(3):197-202. PubMed ID: 3552969
    [No Abstract]   [Full Text] [Related]  

  • 30. Vibrio cholerae O139 Bengal: odyssey of a fortuitous variant.
    Ramamurthy T; Yamasaki S; Takeda Y; Nair GB
    Microbes Infect; 2003 Apr; 5(4):329-44. PubMed ID: 12706446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interactions between complement system and bacterial walls].
    Colomb MG; Bensa JC; Chesne S; Aubert B
    Bull Eur Physiopathol Respir; 1983; 19(2):131-6. PubMed ID: 6871492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrophoretic mobility and immune response of outer membrane proteins of Vibrio cholerae O139.
    Pal S; Sasmal D; Guhathakurta B; Nair GB; Bhattacharya SK; Mallick R; Datta A
    FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):143-8. PubMed ID: 8880140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor C acts as a lipopolysaccharide-responsive C3 convertase in horseshoe crab complement activation.
    Ariki S; Takahara S; Shibata T; Fukuoka T; Ozaki A; Endo Y; Fujita T; Koshiba T; Kawabata S
    J Immunol; 2008 Dec; 181(11):7994-8001. PubMed ID: 19017991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and evaluation of a O139 Vibrio cholerae vaccine candidate based on a hemA gene mutation.
    Ravichandran M; Ali SA; Rashid NH; Kurunathan S; Yean CY; Ting LC; Bakar AS; Lalitha P; Zainuddin ZF
    Vaccine; 2006 May; 24(18):3750-61. PubMed ID: 16102875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunosuppressive effects of pathogenic gram-negative bacteria].
    Vorob'ev AA; Borisova EV; Molozhavaia OS; Borisov VA
    Vestn Ross Akad Med Nauk; 2001; (2):21-5. PubMed ID: 11338500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple and convenient microtiter plate assay for the detection of bactericidal antibodies to Vibrio cholerae O1 and Vibrio cholerae O139.
    Boutonnier A; Dassy B; Duménil R; Guénolé A; Ratsitorahina M; Migliani R; Fournier JM
    J Microbiol Methods; 2003 Dec; 55(3):745-53. PubMed ID: 14607417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative characteristics of the preparations of hemolysin of ctx+ and ctx- Vibrio cholerae eltor and Vibrio cholerae O139 strains].
    Men'shikova EA; Podosinnikova LS
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):47-9. PubMed ID: 17163139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India.
    Raghava Mohan V; Raj S; Dhingra MS; Aloysia D'Cor N; Singh AP; Saluja T; Kim DR; Midde VJ; Kim Y; Vemula S; Narla SK; Sah B; Ali M
    PLoS One; 2019; 14(6):e0218033. PubMed ID: 31211792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re-emergence of El Tor vibrio in outbreak of cholera in & around Nagpur.
    Mishra M; Mohammed F; Akulwar SL; Katkar VJ; Tankhiwale NS; Powar RM
    Indian J Med Res; 2004 Nov; 120(5):478-80. PubMed ID: 15591633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of acyl chain fluidity on the lipopolysaccharide-induced activation of complement.
    Wiese A; Grünewald P; Schaper KJ; Seydel U
    J Endotoxin Res; 2001; 7(2):147-55. PubMed ID: 11521095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.